Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 10461: Totum-854 Lowers Blood Pressure in L-NAME-Induced Arterial Hypertension in Mice and in Spontaneous Hypertensive Rat Model

View through CrossRef
Introduction: Arterial Hypertension (AHT) is a major cause of premature death worldwide. We have developed Totum-854 (T-854), a polyphenol-rich botanical composition to reduce the risk of developing AHT. We assessed the chronic effect of T-854 on preventing the development of L-NAME-induced AHT in mice, and the acute effect on blood pressure in spontaneous hypertensive rats (SHR). Methods: 12-week-old C57Bl6/J mice were divided into Control, L-NAME, and L-NAME + T-854 group. L-NAME (100 mg/kg/day) was dissolved in drinking water. Mice received either T-854 (450 mg/kg) or vehicle by gavage once a day for three weeks . The arterial pressure was assessed using the CODA® Tail-Cuff System every week for three weeks. 12-week-old SHR rats received a dose of vehicle or T-854 (1250mg/kg) per os with a 48h-wash-out interval between two gavages, in random order. Arterial pressure was recorded during 24h post-gavage with a radio-telemetry device (HD-S10, DSI) directly implanted into the abdominal aorta. Results: In mice, L-NAME increased systolic (SBP; from 105±3 to 130±1 mmHg, p<0.0001), diastolic (DBP; from 77±3 to 97±2 mmHg, p<0.0001) and mean (MBP; from 86±3 to 108±2 mmHg, p<0.0001) blood pressure along the 3 weeks of treatment. Interestingly, in T-854-supplemented mice, SBP was significantly reduced from the first week of supplementation, and DBP and MBP from the second week of supplementation. After three weeks, T-854 lowered the SBP by 16% (p<0.0001), the DBP by 20% (p<0.05) and the MBP by 18 % (p<0.01), in comparison to L-NAME mice. In the SHR study, SBP and DBP were reduced during 24h recording after T-854 gavage in comparison to vehicle, with a 24h-AUC decreased by 108 ± 87.8 and 84.4 ± 69.3 mmHg.h, respectively. Conclusions: In conclusion, T-854 appears as an efficient strategy to prevent AHT and this effect was confirmed in two different preclinical models: L-NAME-induced AHT in mice and SHR rats.
Title: Abstract 10461: Totum-854 Lowers Blood Pressure in L-NAME-Induced Arterial Hypertension in Mice and in Spontaneous Hypertensive Rat Model
Description:
Introduction: Arterial Hypertension (AHT) is a major cause of premature death worldwide.
We have developed Totum-854 (T-854), a polyphenol-rich botanical composition to reduce the risk of developing AHT.
We assessed the chronic effect of T-854 on preventing the development of L-NAME-induced AHT in mice, and the acute effect on blood pressure in spontaneous hypertensive rats (SHR).
Methods: 12-week-old C57Bl6/J mice were divided into Control, L-NAME, and L-NAME + T-854 group.
L-NAME (100 mg/kg/day) was dissolved in drinking water.
Mice received either T-854 (450 mg/kg) or vehicle by gavage once a day for three weeks .
The arterial pressure was assessed using the CODA® Tail-Cuff System every week for three weeks.
12-week-old SHR rats received a dose of vehicle or T-854 (1250mg/kg) per os with a 48h-wash-out interval between two gavages, in random order.
Arterial pressure was recorded during 24h post-gavage with a radio-telemetry device (HD-S10, DSI) directly implanted into the abdominal aorta.
Results: In mice, L-NAME increased systolic (SBP; from 105±3 to 130±1 mmHg, p<0.
0001), diastolic (DBP; from 77±3 to 97±2 mmHg, p<0.
0001) and mean (MBP; from 86±3 to 108±2 mmHg, p<0.
0001) blood pressure along the 3 weeks of treatment.
Interestingly, in T-854-supplemented mice, SBP was significantly reduced from the first week of supplementation, and DBP and MBP from the second week of supplementation.
After three weeks, T-854 lowered the SBP by 16% (p<0.
0001), the DBP by 20% (p<0.
05) and the MBP by 18 % (p<0.
01), in comparison to L-NAME mice.
In the SHR study, SBP and DBP were reduced during 24h recording after T-854 gavage in comparison to vehicle, with a 24h-AUC decreased by 108 ± 87.
8 and 84.
4 ± 69.
3 mmHg.
h, respectively.
Conclusions: In conclusion, T-854 appears as an efficient strategy to prevent AHT and this effect was confirmed in two different preclinical models: L-NAME-induced AHT in mice and SHR rats.

Related Results

[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED] Guardian Blood Balance –Feel the difference Guardian Blood Balance makes! v1
[RETRACTED]Guardian Blood Balance Reviews (Works Or Hoax) Does Guardian Botanicals Blood Balance AU Really Works? Read Updated Report! Diabetes and Hypertension is such a health p...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
HYPERTENSIVE CRISES: HYPERTENSIVE EMERGENCY AND CRISIS MANAGEMENT DURING ANESTHESIA
HYPERTENSIVE CRISES: HYPERTENSIVE EMERGENCY AND CRISIS MANAGEMENT DURING ANESTHESIA
Introduction: hypertensive crisis is characterized by an acute and massive increase in blood pressure. Hypertensive crises encompass several clinical situations with different seve...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
The Correlation Age and Body Mass Index (BMI) Score with Blood Pressure in Hypertension Patient
The Correlation Age and Body Mass Index (BMI) Score with Blood Pressure in Hypertension Patient
Hypertension is a condition where the blood vessels have high blood pressure against the pressure of the artery walls when the blood is pumped by the heart throughout the body. The...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
14th Annual Meeting, December 1980, Canberra1. Effect of dexamethasone on pineal β‐adrenoceptors. C. A. Maxwell, A. Foldes, N. T. Hinks and R. M. Hoskinson2. A clinicopathological ...

Back to Top